Ulster Hospital

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Colorectal cancer1 trial
• Crohn's disease1 trial
• Gastric and oesophageal cancer1 trial
• Heart failure1 trial
• Liver and biliary tract cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 33 trials
• Phase 1/21 trial

Status

• Recruiting3 trials
• Completed1 trial

Lead sponsor

• Bold Therapeutics, Inc.1 trial
• Cytokinetics1 trial
• Hamilton Health Sciences Corporation1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Recruiting

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  NCT07577843· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  NCT06736574· Phase 3· Cytokinetics· Source

  Contact: Cytokinetics MD

• Recruiting

  BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours

  NCT04421820· Phase 1/2· Bold Therapeutics, Inc.· Source

  Contact: Rachel Boyd

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Crohn's disease1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Heart failure1 recruiting
• Liver and biliary tract cancer1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Completed

  Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

  NCT03020303· Phase 3· Hamilton Health Sciences Corporation· Source